Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19

Health Information and Quality Authority (HIQA)
Record ID 32018001670
Authors' objectives: The purpose of this report was to provide advice to the National Public Health Emergency Team (NPHET) on the following policy question: "What is the emerging evidence in relation to (i) pharmaceutical and (ii) lifestyle interventions post diagnosis of COVID-19 in the community aimed at minimising progression to severe disease?" The response to the policy question was informed by an evidence synthesis considering two elements: 1. Evidence for the effectiveness of (i) pharmaceutical and (ii) nonpharmaceutical interventions, in the community setting, aimed at reducing progression to severe disease in individuals with confirmed or suspected COVID-19 2. Input from the COVID-19 Expert Advisory Group
Project Status: Completed
Year Published: 2021
Requestor: National Public Health Emergency Team (NPHET)
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Ireland
MeSH Terms
  • SARS-CoV-2
  • COVID-19
  • Ambulatory Care
  • Disease Progression
  • Coronavirus Infections
  • SARS-CoV-2
  • COVID-19
  • Ambulatory Care
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name:
Contact Email:
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.